People who get infected with COVID-19 have an unpredictable risk to worsen and die. This makes it hard to decide who can quarantine at home and who should be treated at a hospital. Researchers think the risk may be related to a person s B and T cells. B and T cells are the major components of a person s immune response.
To examine how immune cells respond to COVID-19 infection.
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.
Study type: Observational
Estimated Enrollment: 150 participants
Estimated Study Start Date: April 27, 2020
Estimated Study Completion Date: December 1, 2024
Adults ages 18 and older who have a confirmed or suspected COVID-19 infection or had COVID-19 in the past, as well as people who have not had COVID-19.
Thank you for your interest in advancing COVID-19 treatments.
Please fill out this contact form to be connected to a member of the study team. The following information that you enter will only be authorized to be shared with the research team conducting this specific study.
If you have any difficulties or questions, please contact our support specialists at [email protected]
For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you’ll be connected to the study team.